skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 379  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
Material Type:
Article
Add to My Research

IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients

Blood, 2015-05, Vol.125 (22), p.3501-3508 [Peer Reviewed Journal]

2015 American Society of Hematology ;2015 by The American Society of Hematology. ;2015 by The American Society of Hematology 2015 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2014-12-615757 ;PMID: 25862561

Full text available

2
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation
Material Type:
Article
Add to My Research

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3249-3256, Article 3249 [Peer Reviewed Journal]

2014 by American Society of Clinical Oncology. ;2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2013.53.8157 ;PMID: 25154831

Full text available

3
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
Material Type:
Article
Add to My Research

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Blood advances, 2020-11, Vol.4 (21), p.5414-5424 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 2473-9529 ;EISSN: 2473-9537 ;DOI: 10.1182/bloodadvances.2020003092 ;PMID: 33147337

Full text available

4
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
Material Type:
Article
Add to My Research

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Journal of clinical oncology, 2013-04, Vol.31 (12), p.1530-1538 [Peer Reviewed Journal]

2014 INIST-CNRS ;2013 by American Society of Clinical Oncology 2013 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.45.0247 ;PMID: 23478054

Full text available

5
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433
Material Type:
Article
Add to My Research

Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433

Haematologica (Roma), 2021-01, Vol.106 (1), p.46-55 [Peer Reviewed Journal]

Copyright© 2021 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2019.237230 ;PMID: 32001530

Full text available

6
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication
Material Type:
Article
Add to My Research

Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication

Nature communications, 2024-03, Vol.15 (1), p.2749-2749 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-47056-3 ;PMID: 38553461

Full text available

7
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality
Material Type:
Article
Add to My Research

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality

Blood, 2014-07, Vol.124 (2), p.287-295 [Peer Reviewed Journal]

2014 American Society of Hematology ;2014 by The American Society of Hematology. ;2014 by The American Society of Hematology 2014 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2014-01-550566 ;PMID: 24797298

Full text available

8
Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning
Material Type:
Article
Add to My Research

Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4912-4920 [Peer Reviewed Journal]

2008 INIST-CNRS ;Copyright © 2008, American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2007.15.4757 ;PMID: 18794548

Full text available

9
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program
Material Type:
Article
Add to My Research

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

Blood, 2009-04, Vol.113 (15), p.3604-3611 [Peer Reviewed Journal]

2009 American Society of Hematology ;2009 INIST-CNRS ;2009 by The American Society of Hematology 2009 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2008-08-175323 ;PMID: 19190248

Full text available

10
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia
Material Type:
Article
Add to My Research

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2859-2867 [Peer Reviewed Journal]

2015 INIST-CNRS ;2010 by American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2009.27.1460 ;PMID: 20439626

Full text available

11
Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells
Material Type:
Article
Add to My Research

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells

CPT: pharmacometrics and systems pharmacology, 2019-05, Vol.8 (5), p.285-295 [Peer Reviewed Journal]

2019 The Authors published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2163-8306 ;EISSN: 2163-8306 ;DOI: 10.1002/psp4.12388 ;PMID: 30848084

Full text available

12
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program
Material Type:
Article
Add to My Research

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program

Blood, 2013-01, Vol.121 (1), p.197-206 [Peer Reviewed Journal]

2013 American Society of Hematology ;2014 INIST-CNRS ;2013 by The American Society of Hematology 2013 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-03-417667 ;PMID: 23109243

Full text available

13
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia
Material Type:
Article
Add to My Research

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia

Haematologica (Roma), 2017-07, Vol.102 (7), p.1291-1298 [Peer Reviewed Journal]

Copyright© 2017 Ferrata Storti Foundation. ;Copyright© 2017 Ferrata Storti Foundation 2017 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2017.164459 ;PMID: 28341733

Full text available

14
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
Material Type:
Article
Add to My Research

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

Haematologica (Roma), 2019-02, Vol.104 (2), p.380-391 [Peer Reviewed Journal]

Copyright © 2019 Ferrata Storti Foundation. ;Copyright © 2019 Ferrata Storti Foundation 2019 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2018.200253 ;PMID: 30262560

Full text available

15
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose
Material Type:
Article
Add to My Research

Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose

Blood, 2009-09, Vol.114 (13), p.2606-2616 [Peer Reviewed Journal]

2009 American Society of Hematology ;2015 INIST-CNRS ;2009 by The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2009-03-208355 ;PMID: 19608747

Full text available

16
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation
Material Type:
Article
Add to My Research

Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1278-1287 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;ISSN: 0268-3369 ;EISSN: 1476-5365 ;DOI: 10.1038/s41409-018-0155-z ;PMID: 29581480

Full text available

17
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
Material Type:
Article
Add to My Research

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

Blood advances, 2019-11, Vol.3 (21), p.3393-3405 [Peer Reviewed Journal]

2019 American Society of Hematology ;ISSN: 2473-9529 ;EISSN: 2473-9537 ;DOI: 10.1182/bloodadvances.2019000449 ;PMID: 31714961

Full text available

18
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Relapsed, Refractory, and Transformed Indolent Non-Hodgkin's Lymphoma
Material Type:
Article
Add to My Research

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Relapsed, Refractory, and Transformed Indolent Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2008-01, Vol.26 (2), p.211-217 [Peer Reviewed Journal]

2008 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2007.11.5477 ;PMID: 18056679

Full text available

19
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria
Material Type:
Article
Add to My Research

Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria

Blood, 2007-03, Vol.109 (6), p.2618-2621 [Peer Reviewed Journal]

2007 American Society of Hematology ;2007 by The American Society of Hematology 2007 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2006-06-022848 ;PMID: 17148589

Full text available

20
Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia
Material Type:
Article
Add to My Research

Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia

Frontiers in pediatrics, 2022-01, Vol.9, p.805189-805189 [Peer Reviewed Journal]

Copyright © 2022 Keogh, Dalle, Admiraal and Pulsipher. ;Copyright © 2022 Keogh, Dalle, Admiraal and Pulsipher. 2022 Keogh, Dalle, Admiraal and Pulsipher ;ISSN: 2296-2360 ;EISSN: 2296-2360 ;DOI: 10.3389/fped.2021.805189 ;PMID: 35071142

Full text available

Results 1 - 20 of 379  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (222)

Refine My Results

Creation Date 

From To
  1. Before 2003  (11)
  2. 2003 To 2007  (19)
  3. 2008 To 2012  (61)
  4. 2013 To 2018  (169)
  5. After 2018  (122)
  6. More options open sub menu

Resource Type 

  1. Articles  (374)
  2. Patents  (2)
  3. Book Chapters  (2)
  4. Text Resources  (1)
  5. More options open sub menu

Language 

  1. Japanese  (49)
  2. French  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait